| Literature DB >> 27827890 |
Subramaniyan Bharathiraja1, Hansu Seo2, Panchanathan Manivasagan3, Madhappan Santha Moorthy4, Suhyun Park5, Jungwan Oh6,7.
Abstract
C-phycocyanin, a natural blue-colored pigment-protein complex was explored as a novel photosensitizer for use in low-level laser therapy under 625-nm laser illumination. C-phycocyanin produced singlet oxygen radicals and the level of reactive oxygen species (ROS) were raised in extended time of treatment. It did not exhibit any visible toxic effect in the absence of light. Under 625-nm laser irradiation, c-phycocyanin generated cytotoxic stress through ROS induction, which killed MDA-MB-231 breast cancer cells depending on concentrations. Different fluorescent staining of laser-treated cells explored apoptotic cell death characteristics like the shrinking of cells, cytoplasmic condensation, nuclei cleavage, and the formation of apoptotic bodies. In conclusion, phycocyanin is a non-toxic fluorescent pigment that can be used in low-level light therapy.Entities:
Keywords: laser therapy; photodynamic therapy; phycocyanin; reactive oxygen species
Mesh:
Substances:
Year: 2016 PMID: 27827890 PMCID: PMC6273603 DOI: 10.3390/molecules21111470
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Systematic representation of c-phycocyanin uptake by MBA-MD-231 cells and subsequent photodynamic therapy using a 625-nm laser.
Figure 1Chemical structure and absorbance spectrum; (A) Chemical structure of c-phycocyanin; and (B) UV-VIS absorbance spectrum of c-phycocyanin dissolved in water at the concentration of 10 μg·mL−1.
Figure 2Screening of free radical generation efficacy by c-phycocyanin under 625-nm laser illumination at 80 mW·cm−2 using SOSG (A) and DPBF (B) assays.
Figure 3Fluorescence microscopic images demonstrate cellular uptake of c-phycocyanin by MBA-MD-231 using an excitation/emission range of 600/650-nm.
Figure 4MBA-MD-231 cell viability (A) Biocompatibility of c-phycocyanin with MBA-MD-231 cells; and (B) different concentrations of c-phycocyanin-treated MBA-MD-231 cells showed cytotoxicity after PDT treatment using a 625-nm laser at 80 mW·cm−2 for 30 min. Data is expressed as mean ± SD of the three experiments. Percentage of cytotoxicity is expressed relative to untreated controls (* significant p < 0.05).
Figure 5Bright field and fluorescent microscopic images of PDT-treated MBA-MD-231 cells with or without phycocyanin using 625-nm laser irradiation for 30 min at a power density of 80 mW·cm−2.
Figure 6DCFH-DA staining of MBA-MD-231 cells following 1 h of PDT treatment with or without phycocyanin. Rho-123 staining demonstrated loss of mitochondrial membrane potential after 24 h of PDT treatment. The PDT treatment was performed using 625-nm laser for 30 min at 80 mW·cm−2 power density.
Figure 7Annexin V-Cy3/6-CFDA staining of MBA-MD-231cells after 6 h of PDT treatment with or without phycocyanin, using a 625-nm laser at a power density of 80 mW·cm−2 for 30 min.